Skip to Content

M D 34 (Doxycycline Hyclate Delayed-Release 200 mg)

Pill with imprint M D 34 is White, Capsule-shape and has been identified as Doxycycline Hyclate Delayed-Release 200 mg. It is supplied by Mylan Pharmaceuticals Inc..

Doxycycline is used in the treatment of acne; actinomycosis; anthrax; amebiasis; gonococcal infection, uncomplicated and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy. Doxycycline 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M D 34

Doxycycline hyclate delayed-release 200 mg M D 34

Doxycycline Hyclate Delayed-Release

Imprint
M D 34
Strength
200 mg
Color
White
Size
21.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Miscellaneous antimalarials, Tetracyclines
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-4533
Inactive Ingredients
lactose anhydrous, silicon dioxide, lactose monohydrate, povidone, corn starch, sodium chloride, sodium lauryl sulfate, stearic acid, magnesium silicate, triethyl citrate, hypromellose phthalate (24% phthalate, 55 cst)

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "M D 34"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.